Evidence map›Paper›PMID 23657598›Full record

ArticleMolecular biology reports2013

High glucose induces mitochondrial p53 phosphorylation by p38 MAPK in pancreatic RINm5F cells.

Luis A Flores-López, Margarita Díaz-Flores, Rebeca García-Macedo, Alejandro Ávalos-Rodríguez, Marcela Vergara-Onofre, Miguel Cruz, Alejandra Contreras-Ramos, Mina Konigsberg, Clara Ortega-Camarillo

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Is p53 Involved in Tissue-Specific Insulin Resistance Formation?Oxidative medicine and cellular longevity · 2017
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Luis A Flores-LópezUnidad de Investigación Médica en Bioquímica, HE, Centro Médico Nacional Siglo XXI. IMSS., Av. Cuauhtémoc 330, Col Doctores, Del. Cuauhtémoc, México, DF, Mexico.
Margarita Díaz-Flores
Rebeca García-Macedo
Alejandro Ávalos-Rodríguez
Marcela Vergara-Onofre
Miguel Cruz
Alejandra Contreras-Ramos
Mina Konigsberg
Clara Ortega-Camarillo
Centro Medico Nacional Siglo XXI · MXUniversidad Autónoma Metropolitana · MXHospital Infantil de México Federico Gómez · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pancreatic β-cell death in type 2 diabetes has been related to p53 subcellular localisation and phosphorylation. However, the mechanisms by which p53 is phosphorylated and its activation in response to oxidative stress remain poorly understood. Therefore, the aim of this study was to investigate mitochondrial p53 phosphorylation, its subcellular localisation and its relationship with apoptotic induction in RINm5F cells cultured under high glucose conditions. Our results show that p53 phosphorylation in the mitochondrial fraction was greater at ser392 than at ser15. This increased phosphorylation correlated with an increase in reactive oxygen species, a decrease in the Bcl-2/Bax ratio, a release of cytochrome c and an increase in the rate of apoptosis. We also observed a decline in ERK 1/2 phosphorylation over time, which is an indicator of cell proliferation. To identify the kinase responsible for phosphorylating p53, p38 mitogen-activated protein kinase (MAPK) activation was analysed. We found that high glucose induced an increase in p38 MAPK phosphorylation in the mitochondria after 24-72 h. Moreover, the phosphorylation of p53 (ser392) by p38 MAPK in mitochondria was confirmed by colocalisation studies with confocal microscopy. The addition of a specific p38 MAPK inhibitor (SB203580) to the culture medium during high glucose treatment blocked p53 mobilisation to the mitochondria and phosphorylation; thus, the release of cytochrome c and the apoptosis rate in RINm5F cells decreased. These results suggest that mitochondrial p53 phosphorylation by p38 MAPK plays an important role in RINm5F cell death under high glucose conditions.

Indexed as

AnimalsBlotting, WesternCell LineDNA PrimersFlow CytometryGlucoseImmunoprecipitationInsulin-Secreting CellsMicroscopy, ConfocalMitochondriap38 Mitogen-Activated Protein KinasesPhosphorylationRatsReactive Oxygen SpeciesReal-Time Polymerase Chain ReactionTumor Suppressor Protein p53DNA PrimersGlucosep38 Mitogen-Activated Protein KinasesReactive Oxygen SpeciesTumor Suppressor Protein p53

Identifiers

PMID23657598
OpenAlexW1969302397

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.